Skip to content

ACCELERON PHARMA INC.: filings

Every ACCELERON PHARMA INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 33 filings, each linked to its SEC index.

Filing record ends 2021-11-04

The latest filing in this captured record is a 10-Q filed 2021-11-04. No later filing is in the SEC companyfacts record captured on 2026-09-22. ACCELERON PHARMA INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2021-11-04fiscal Q3 2021391170001280600-21-000078
10-Q2021-08-05fiscal Q2 2021381110001280600-21-000066
10-Q2021-05-06fiscal Q1 202133710001280600-21-000038
10-K2021-02-25fiscal FY 2020401260001280600-21-000017
10-Q2020-11-05fiscal Q3 202034990001280600-20-000078
10-Q2020-08-06fiscal Q2 202034950001280600-20-000059
10-Q2020-05-11fiscal Q1 202034730001280600-20-000040
10-K2020-02-27fiscal FY 2019401240001280600-20-000012
10-Q2019-11-06fiscal Q3 2019371030001280600-19-000052
10-Q2019-08-05fiscal Q2 201937990001280600-19-000044
10-Q2019-05-09fiscal Q1 201936740001280600-19-000032
10-K2019-02-27fiscal FY 2018381230001280600-19-000012
10-Q2018-10-30fiscal Q3 201835930001280600-18-000063
10-Q2018-08-02fiscal Q2 201834910001280600-18-000057
10-Q2018-05-08fiscal Q1 201833690001280600-18-000030
10-K2018-02-27fiscal FY 2017381340001280600-18-000016
10-Q2017-11-07fiscal Q3 201733880001280600-17-000055
10-Q2017-08-03fiscal Q2 201733880001280600-17-000048
10-Q2017-05-08fiscal Q1 201737760001280600-17-000029
10-K2017-03-01fiscal FY 2016401400001280600-17-000008
10-Q2016-11-03fiscal Q3 201635920001280600-16-000114
10-Q2016-08-04fiscal Q2 201634880001280600-16-000102
10-Q2016-05-05fiscal Q1 201639800001280600-16-000082
10-K2016-02-25fiscal FY 2015411420001280600-16-000072
10-Q2015-11-04fiscal Q3 201532860001280600-15-000059
10-Q2015-08-06fiscal Q2 201532880001280600-15-000045
10-Q2015-05-07fiscal Q1 201532660001280600-15-000035
10-K2015-03-02fiscal FY 2014361280001280600-15-000009
10-Q2014-11-07fiscal Q3 2014361060001280600-14-000029
10-Q2014-08-12fiscal Q2 2014361040001280600-14-000010
10-Q2014-05-15fiscal Q1 201431630001104659-14-039037
10-K2014-03-17fiscal FY 2013371370001047469-14-002530
10-Q2013-11-14fiscal Q3 201332870001104659-13-084662

Inspect the source

Entity
ACCELERON PHARMA INC. / CIK 0001280600
Captured
SEC response SHA-256
293bbf04000ea375fd846f4ac43793cb5fa3b59bde7ba5840c89b9bbd3a62ee8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001280600.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))